(-0.52%) 5 022.75 points
(-0.43%) 37 844 points
(-0.66%) 17 432 points
(1.41%) $83.90
(0.11%) $1.759
(0.07%) $2 399.70
(0.28%) $28.46
(-0.19%) $952.70
(-0.01%) $0.939
(0.04%) $11.05
(0.02%) $0.804
(-0.03%) $93.88
4 days till quarter result
(bmo 2024-04-23)
Expected move: +/- 3.55%
Live Chart Being Loaded With Signals
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems...
Stats | |
---|---|
Today's Volume | 38 348.00 |
Average Volume | 29 298.00 |
Market Cap | 241.29M |
EPS | $0 ( 2024-01-30 ) |
Next earnings date | ( $0 ) 2024-04-23 |
Last Dividend | $0.300 ( 2023-12-14 ) |
Next Dividend | $0 ( N/A ) |
P/E | 14.71 |
ATR14 | $0.106 (0.16%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-27 | Koopman Brian | Buy | 500 | Employee Stock Option - Right to Buy |
2023-06-15 | Koopman Brian | Sell | 60 | Common Stock |
2023-05-18 | Richins Paul O | Sell | 700 | Common Stock |
2023-03-17 | Richins Paul O | Sell | 150 | Common Stock |
2023-02-08 | Payne Barbara A | Sell | 500 | Common Stock |
INSIDER POWER |
---|
-23.96 |
Last 100 transactions |
Buy: 7 349 | Sell: 108 142 |
Volume Correlation
Utah Medical Products Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Utah Medical Products Inc Correlation - Currency/Commodity
Utah Medical Products Inc Financials
Annual | 2023 |
Revenue: | $50.22M |
Gross Profit: | $24.35M (48.47 %) |
EPS: | $4.58 |
Q4 | 2023 |
Revenue: | $12.33M |
Gross Profit: | $6.23M (50.51 %) |
EPS: | $1.180 |
Q3 | 2023 |
Revenue: | $12.51M |
Gross Profit: | $7.36M (58.85 %) |
EPS: | $1.080 |
Q2 | 2023 |
Revenue: | $12.87M |
Gross Profit: | $7.74M (60.15 %) |
EPS: | $1.160 |
Financial Reports:
No articles found.
Utah Medical Products Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.290 (N/A) |
$0.295 (N/A) |
$0.295 (N/A) |
$0.295 (N/A) |
$0.295 (N/A) |
$0.300 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.150 | 2004-06-14 |
Last Dividend | $0.300 | 2023-12-14 |
Next Dividend | $0 | N/A |
Payout Date | 2024-01-03 | |
Next Payout Date | N/A | |
# dividends | 79 | -- |
Total Paid Out | $21.80 | -- |
Avg. Dividend % Per Year | 1.09% | -- |
Score | 5.44 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.36 | |
Div. Directional Score | 9.05 | -- |
Year | Amount | Yield |
---|---|---|
2004 | $0.450 | 1.75% |
2005 | $0.630 | 2.84% |
2006 | $0.780 | 2.55% |
2007 | $0.885 | 2.68% |
2008 | $0.905 | 3.06% |
2009 | $0.925 | 3.86% |
2010 | $1.665 | 5.63% |
2011 | $0.945 | 3.50% |
2012 | $0.965 | 3.53% |
2013 | $0.985 | 2.57% |
2014 | $1.005 | 1.94% |
2015 | $1.025 | 1.77% |
2016 | $1.045 | 1.78% |
2017 | $1.065 | 1.49% |
2018 | $1.085 | 1.37% |
2019 | $1.105 | 1.30% |
2020 | $1.125 | 1.05% |
2021 | $2.86 | 3.41% |
2022 | $1.165 | 1.20% |
2023 | $1.185 | 1.21% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.393 | 1.500 | 2.15 | 3.22 | [0 - 0.5] |
returnOnAssetsTTM | 0.123 | 1.200 | 5.91 | 7.09 | [0 - 0.3] |
returnOnEquityTTM | 0.135 | 1.500 | 9.61 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.257 | -1.000 | 7.43 | -7.43 | [0 - 1] |
currentRatioTTM | 22.56 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 59.87 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 19.72 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.00252 | -1.500 | 9.96 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -8.51 | 1.000 | -4.26 | -4.26 | [3 - 30] |
operatingCashFlowPerShareTTM | 6.14 | 2.00 | 7.95 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 5.96 | 2.00 | 7.02 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.00267 | -1.500 | 9.99 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.503 | 1.000 | 4.95 | 4.95 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.354 | 1.000 | 4.92 | 4.92 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 65.15 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.313 | 0.800 | -1.248 | -0.998 | [0.5 - 2] |
Total Score | 10.73 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 15.30 | 1.000 | 8.56 | 0 | [1 - 100] |
returnOnEquityTTM | 0.135 | 2.50 | 9.75 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 5.96 | 2.00 | 8.01 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.697 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 6.14 | 2.00 | 7.95 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.257 | 1.500 | 7.43 | -7.43 | [0 - 1] |
pegRatioTTM | 1.497 | 1.500 | 3.35 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.526 | 1.000 | 10.00 | 0 | [0.1 - 0.5] |
Total Score | 7.36 |
Utah Medical Products Inc
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators